Acid Suppression Therapy in an Internal Medicine Department
Keywords:
Acid suppression therapy, overuse, clinical recommendationsAbstract
Background: The use of acid suppression (AST) in the prophylaxis of stress ulcer is well defined in patients in Intensive Care units,
although there is lack of data in the general practice. Appropriate recommendations include: upper gastrointestinal disease or
NSAID-induced gastropathy.
The aims of this study were to determine the frequency and the
predictive factors for inappropriate administration of AST on admission, during the hospitalization and on discharge to the general
practice and to determine the costs to the health care system.
Methods: A retrospective review of clinical files was carried out from the 1st of January to 30th of June of 2010 in our Internal
Medicine department. The medications used were esomeprazole, ranitidine and sucralfate.
Results: we assessed 511 patients with a mean age of 80.5years. 30% of the patients took AST before admission. Their use was
inappropriate in 69% of them. Among hospitalized patients, 89% of patients started AST during the hospitalization, and these 76%
were unnecessary. At discharge, 48% of patients used AST, and most of them (61%) had no such indication.
The inappropriate administration of AST increases the cost per patient.
Conclusion: Results agree with the literature, with a high
frequency of incorrect AST prescription. A more accurate use of AST is recommended to avoid side effects and to reduce costs.
Downloads
References
Heidelbaugh J, Inadomi J. Magnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized Patients, Am J Gastroenterol, 2006; 101:2200-2205.
American society of health system pharmacists, ASHP therapeutic guidelines on stress ulcer prophylaxis, Am J Health-Syst Pharm, 1999; 56:347-379.
Gupta R, Garg P, Kottoor R et al. Overuse of Acid Suppression Therapy in Hospitalized Patients; Southern Medical Journal, 2010;103(3):207-211.
Nardino R, Vender R, Herbert P. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol, 2000; 95:3118-3122.
Mohebbi L, Hesch K. Stress prophylaxis in intensive care unit, Bayl univ med cent, 2009; 22(4):373-376.
Martín-Echevarría E, Juliá A, Torralba V, Zapata. Assessing the use of proton pump inhibitors in an internal medicine department; Rev Esp Enferm Dig 2008; 100(2):76-81.
Mohammed A. Hospital-Acquired Gastrointestinal bleeding outside the critical care unit, journal of hospital medicine 2006; 1(1):13-20.
Dubois R, Melmed G. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxigenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy, Aliment Pharmacol Ther 2004; 19:197-208.
Abraham N, Bhatt D, Scheiman J et al. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; Circulation2008; 118;1894-1909.
Holtmann G, Howden C. Management of peptic ulcer bleeding-the roles of proton pump inhibitors and Helicobacter pylori eradication. Aliment Pharmacol Ther, 2004; 19: S66-S77.
Miano T, Houle T, Reichert M. Nosocomial Pneumonia risk and stress ulcer Prophylaxis, Chest 2009; 136; 440-447.
Simpson I, Marshall M, Pilmore H et al. Proton pump inhibitors and acute intersticial nephritis: Report and analysis of 15 cases,Nephrology 2006; 11: 381-385.
Sholl A, Feldman M, Ginsburg C. Pharmacology of antiulcer medications 2009; uptodate.
Soll A, Feldman M, Ginsburg C. Pharmacology of antiulcer medications
; UpToDate
Gingold A, Narasimhan G, Augello S, Clain D. The Prevalence of Proton Pump Inhibitor Use in Hospitalized Patients, Practical Gastroenteroloy 2006: 24-34.
Rebekah R, May D. stress ulcer prophylaxis in hospitalized patients not in intensive care units, american journal of health-system pharmacy 2007; 64(13): 1396-1400.
Noguerado A, Rodriguez B, Zelaya C et al. Use of acid-suppressive medications in hospitalized patients. An Med Interna 2002; 19:555-556
Additional Files
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna